Abstract
This paper focuses on the recent development of rule-based methods and their applications to the drug discovery process. For a given target, the path for designing new drugs with a lower attrition rate is based on an effective mining of the huge amount of experimental in vitro and in vivo data which has been collected. These data often come in various formats, from many different areas such as chemistry, biology, pharmacology, toxicity and extraction of the critical information is not an easy task. To guide the multi-objective optimization, we have developed a decision-support system (KEM®), based on the Galois lattices theory and constraint satisfaction programming (CSP). After a brief overview of machine learning applications, we will describe the methodology used in KEM for data mining and prediction. Two examples of applications in the drug discovery area will be discussed.
Keywords: Galois lattices, drug design, multi-objective optimization, structure-activity relationships (SAR), machine learning
Current Computer-Aided Drug Design
Title: Novel Rule-Based Method for Multi-Parametric Multi-Objective Decision Support in Lead Optimization Using KEM
Volume: 4 Issue: 1
Author(s): Mohammad Afshar and Nathalie Jullian
Affiliation:
Keywords: Galois lattices, drug design, multi-objective optimization, structure-activity relationships (SAR), machine learning
Abstract: This paper focuses on the recent development of rule-based methods and their applications to the drug discovery process. For a given target, the path for designing new drugs with a lower attrition rate is based on an effective mining of the huge amount of experimental in vitro and in vivo data which has been collected. These data often come in various formats, from many different areas such as chemistry, biology, pharmacology, toxicity and extraction of the critical information is not an easy task. To guide the multi-objective optimization, we have developed a decision-support system (KEM®), based on the Galois lattices theory and constraint satisfaction programming (CSP). After a brief overview of machine learning applications, we will describe the methodology used in KEM for data mining and prediction. Two examples of applications in the drug discovery area will be discussed.
Export Options
About this article
Cite this article as:
Afshar Mohammad and Jullian Nathalie, Novel Rule-Based Method for Multi-Parametric Multi-Objective Decision Support in Lead Optimization Using KEM, Current Computer-Aided Drug Design 2008; 4 (1) . https://dx.doi.org/10.2174/157340908783769238
DOI https://dx.doi.org/10.2174/157340908783769238 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Platelet Glycoprotein Ib and Its Antithrombotic Potential
Current Pharmaceutical Design Mechanisms of Endothelial Dysfunction: Clinical Significance and Preventive Non-Pharmacological Therapeutic Strategies
Current Pharmaceutical Design Neuroprotection by Methylene Blue in Cerebral Global Ischemic Injury Induced Blood-Brain Barrier Disruption and Brain Pathology: A Review
CNS & Neurological Disorders - Drug Targets Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm
Current Pharmaceutical Design Role of Mitochondrial Translocator Protein (18 kDa) on Mitochondrial- Related Cell Death Processes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Fatty Acid-Mediated Inhibition of Metal Binding to the Multi-Metal Site on Serum Albumin: Implications for Cardiovascular Disease
Current Topics in Medicinal Chemistry Toll-Like Receptors: Link between “Danger” Ligands and Plaque Instability
Current Drug Targets Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations
Current Neurovascular Research New Perspectives on Acetaminophen
Current Cardiology Reviews Follistatin-like 1 in Cardiovascular Disease and Inflammation
Mini-Reviews in Medicinal Chemistry Cardioprotective Properties of HDL: Structural and Functional Considerations
Current Medicinal Chemistry Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists
Recent Patents on Cardiovascular Drug Discovery Antisense Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design A More Accurate Approach to Molecular Genetics Analysis in Vascular Disease
Cardiovascular & Hematological Disorders-Drug Targets The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Cardioprotection Techniques: Preconditioning, Postconditioning and Remote Con-ditioning (Basic Science)
Current Pharmaceutical Design The Relationship Between Dietary Lipids and Serum Visfatin and Adiponectin Levels in Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets